CAS 313268-18-7

Fórmula: C22H20Br2N2O2

InChI: InChI=1S/C22H20Br2N2O2/c1-28-18-4-2-3-16(11-18)25-12-17(27)13-26-21-7-5-14(23)9-19(21)20-10-15(24)6-8-22(20)26/h2-11,17,25,27H,12-13H2,1H3

Clave InChI: LEICNUMXFWNCSJ-UHFFFAOYSA-N

SMILES: COC1=CC=CC(=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O

P7C3-OMe

CAS: 313268-18-7

P7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.

Fórmula: C₂₂H₂₀Br₂N₂O₂

Pureza: 97.95%

Forma y color: Solid

Peso molecular: 504.214

Ref: TM-T10012

P7C3-OMe

CAS: 313268-18-7

P7C3-OMe

Fórmula: C₂₂H₂₀Br₂N₂O₂

Pureza: ≥95%

Peso molecular: 504.21

Ref: 54-BUP03564

1-(3,6-Dibromocarbazol-9-yl)-3-(3-methoxyanilino)propan-2-ol

CAS: 313268-18-7

Fórmula: C₂₂H₂₀Br₂N₂O₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 504.2144

Ref: IN-DA01V2K8

P7C3-OMe

CAS: 313268-18-7

P7C3-OMe is a synthetic substance that has neuroprotective properties against aminopropyl carbazole, which is an organic compound that has been shown to cause neural malformation. P7C3-OMe also inhibits the pancreatic lipase enzyme, which is involved in the digestion of triglycerides and other lipids. It has antihistaminic effects, which may be due to its ability to inhibit histamine release in vivo. P7C3-OMe also inhibits pancreatic lipase, an enzyme that hydrolyzes triglycerides and other lipids in the digestive system.

Fórmula: C₂₂H₂₀Br₂N₂O₂

Pureza: Min. 95%

Peso molecular: 504.2 g/mol

Ref: 3D-NMA26818